Page 224 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 224
Viral Hepatitis: Hepatitis A, B, D E Clinical (Except Therapy) (Cont.)
YI P0610 DYNAMIC PREDICTION OF INACTIVE CHRONIC HEPATITIS
B USING REPEATED HBSAG AND HBV DNA LEVEL
MEASUREMENTS THROUGH LONG-TERM FOLLOW-UP
Willem Pieter Brouwer*, Henry L.-Y. Chan, Maurizia R. Brunetto,
Michelle Martinot-Peignoux, Pauline Arends, Markus Cornberg,
Beatrice Cherubini, Alex J. Thompson,Yun-Fan Liaw, Patrick Marcellin,
Harry L. Janssen, Bettina E. Hansen, The Netherlands
YI P0611 TRAJECTORIES OF HEPATITIS B SURFACE ANTIGEN AND
ASSOCIATIONS WITH HEPATOCELLULAR CARCINOMA,
LIVER CIRRHOSIS, AND HBSAG SEROCLEARANCE AMONG
CHRONIC HEPATITIS B CARRIERS WITH LOW VIRAL
LOADS
Jessica Liu*, Hwai-I Yang, Mei-Hsuan Lee, Richard Batrla-Utermann,
Chin-Lan Jen, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Chien-
Jen Chen, Taiwan
YI P0612 INTERFERON-GAMMA-INDUCIBLE PROTEIN 10
PROMOTER POLYMORPHISM RELATED WITH END-OF-
ePOSTERS TREATMENT HBSAG LEVELS AND HAD COMPLEMENTARY
ROLE IN PREDICTION OF SUSTAINED VIROLOGIC
RESPONSE TO PEGINTERFERON IN HBEAG-NEGATIVE
CHRONIC HEPATITIS B: MULTICENTER STUDY
Kessarin Thanapirom*, Sirinporn Suksawatamnuay,
Wattana Sukeepaisarnjareon, Tawesak Tanwandee, Satawat Thongsawat,
Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan,
Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool,
Bubpha Pornthisarn, Supot Tantipanichtheerakul, Ekawee Sripariwuth,
Woramon Jeamsripong, Teeranun Sanpajit,Yong Poovorawan,
Piyawat Komolmit, Thailand
YI P0613 HEPATITIS B CORE RELATED ANTIGEN MAY BE A MARKER
FOR IMMUNE CONTROL IN HBEAG NEGATIVE CHRONIC
HEPATITIS B INFECTION
Margo J. Van Campenhout*, Willem P. Brouwer, Harry L. Janssen,
Qing Xie, Qin Zhang, Fehmi Tabak, Adrian Streinu-Cercel,
Jiyao Wang, Gertine van Oord, Robert J. de Knegt, André Boonstra,
Bettina E. Hansen, The Netherlands
224 The International Liver Congress™ 2015 • ILC Programme
YI P0610 DYNAMIC PREDICTION OF INACTIVE CHRONIC HEPATITIS
B USING REPEATED HBSAG AND HBV DNA LEVEL
MEASUREMENTS THROUGH LONG-TERM FOLLOW-UP
Willem Pieter Brouwer*, Henry L.-Y. Chan, Maurizia R. Brunetto,
Michelle Martinot-Peignoux, Pauline Arends, Markus Cornberg,
Beatrice Cherubini, Alex J. Thompson,Yun-Fan Liaw, Patrick Marcellin,
Harry L. Janssen, Bettina E. Hansen, The Netherlands
YI P0611 TRAJECTORIES OF HEPATITIS B SURFACE ANTIGEN AND
ASSOCIATIONS WITH HEPATOCELLULAR CARCINOMA,
LIVER CIRRHOSIS, AND HBSAG SEROCLEARANCE AMONG
CHRONIC HEPATITIS B CARRIERS WITH LOW VIRAL
LOADS
Jessica Liu*, Hwai-I Yang, Mei-Hsuan Lee, Richard Batrla-Utermann,
Chin-Lan Jen, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Chien-
Jen Chen, Taiwan
YI P0612 INTERFERON-GAMMA-INDUCIBLE PROTEIN 10
PROMOTER POLYMORPHISM RELATED WITH END-OF-
ePOSTERS TREATMENT HBSAG LEVELS AND HAD COMPLEMENTARY
ROLE IN PREDICTION OF SUSTAINED VIROLOGIC
RESPONSE TO PEGINTERFERON IN HBEAG-NEGATIVE
CHRONIC HEPATITIS B: MULTICENTER STUDY
Kessarin Thanapirom*, Sirinporn Suksawatamnuay,
Wattana Sukeepaisarnjareon, Tawesak Tanwandee, Satawat Thongsawat,
Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan,
Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool,
Bubpha Pornthisarn, Supot Tantipanichtheerakul, Ekawee Sripariwuth,
Woramon Jeamsripong, Teeranun Sanpajit,Yong Poovorawan,
Piyawat Komolmit, Thailand
YI P0613 HEPATITIS B CORE RELATED ANTIGEN MAY BE A MARKER
FOR IMMUNE CONTROL IN HBEAG NEGATIVE CHRONIC
HEPATITIS B INFECTION
Margo J. Van Campenhout*, Willem P. Brouwer, Harry L. Janssen,
Qing Xie, Qin Zhang, Fehmi Tabak, Adrian Streinu-Cercel,
Jiyao Wang, Gertine van Oord, Robert J. de Knegt, André Boonstra,
Bettina E. Hansen, The Netherlands
224 The International Liver Congress™ 2015 • ILC Programme